These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6430441)

  • 1. Tamoxifen and liver damage.
    Blackburn AM; Amiel SA; Millis RR; Rubens RD
    Br Med J (Clin Res Ed); 1984 Aug; 289(6440):288. PubMed ID: 6430441
    [No Abstract]   [Full Text] [Related]  

  • 2. Benign hepatic cyst in a patient on antiestrogen therapy for metastatic breast cancer.
    Nand S; Gordon LI; Brestan E; Harris C; Brandt T
    Cancer; 1982 Nov; 50(9):1882-3. PubMed ID: 7116312
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatitis during treatment with tamoxifen. Effects on the kinetics of epirubicin].
    Bressollette L; Swirsky H; Kernaleguen D; Carlhant D; Fauquert P; Le Bot MA; Baccino E; Riche C
    Therapie; 1989; 44(2):151-2. PubMed ID: 2756522
    [No Abstract]   [Full Text] [Related]  

  • 4. Tamoxifen-associated hepatocellular damage and agranulocytosis.
    Ching CK; Smith PG; Long RG
    Lancet; 1992 Apr; 339(8798):940. PubMed ID: 1348345
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatty liver and transaminase changes with adjuvant tamoxifen therapy.
    Liu CL; Huang JK; Cheng SP; Chang YC; Lee JJ; Liu TP
    Anticancer Drugs; 2006 Jul; 17(6):709-13. PubMed ID: 16917217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen-associated steatohepatitis--report of three cases.
    Pinto HC; Baptista A; Camilo ME; de Costa EB; Valente A; de Moura MC
    J Hepatol; 1995 Jul; 23(1):95-7. PubMed ID: 8530816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen-induced hepatotoxicity.
    Ahbeddou N; Belbaraka R; Fetohi M; Errihani H
    Indian J Cancer; 2011; 48(3):385. PubMed ID: 21921356
    [No Abstract]   [Full Text] [Related]  

  • 8. Tamoxifen-induced steatohepatitis.
    Pratt DS; Knox TA; Erban J
    Ann Intern Med; 1995 Aug; 123(3):236. PubMed ID: 7598311
    [No Abstract]   [Full Text] [Related]  

  • 9. Tamoxifen-induced transient multifocal hepatic fatty infiltration.
    Cai Q; Bensen M; Greene R; Kirchner J
    Am J Gastroenterol; 2000 Jan; 95(1):277-9. PubMed ID: 10638597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.
    Ellmén J; Hakulinen P; Partanen A; Hayes DF
    Breast Cancer Res Treat; 2003 Nov; 82(2):103-11. PubMed ID: 14692654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcemia induced by tamoxifen.
    O'Connell TX
    Am J Surg; 1981 Feb; 141(2):277-8. PubMed ID: 7457749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Jaundice and oxyphenisatin.
    McHardy G; Balart LA
    JAMA; 1970 Jan; 211(1):83-5. PubMed ID: 5466895
    [No Abstract]   [Full Text] [Related]  

  • 13. Modulation of tamoxifen-induced hepatotoxicity by tamoxifen-phospholipid complex.
    Jena SK; Suresh S; Sangamwar AT
    J Pharm Pharmacol; 2015 Sep; 67(9):1198-206. PubMed ID: 25904227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced liver injury associated with ezetimibe therapy.
    Liu Q; Tobias H; Petrovic LM
    Dig Dis Sci; 2007 Feb; 52(2):602-5. PubMed ID: 17219067
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatoxic effects of rifampicin].
    Lechner HJ; Reimers D
    Prax Pneumol; 1973 Apr; 27(4):241-9. PubMed ID: 4698443
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical evaluation of liver and pancreas following selective and subselective angiography.
    Goldstein HM; Bookstein JJ
    Radiology; 1974 May; 111(2):293-5. PubMed ID: 4818966
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mild forms of acute alcoholic liver damage: significance and differential diagnosis].
    Linhart P; Kommerell B; Vereschild N
    Dtsch Med Wochenschr; 1973 May; 98(19):983-8. PubMed ID: 4701111
    [No Abstract]   [Full Text] [Related]  

  • 18. [The combined estrogen-gestagen treatment of metastasizing mammary carcinoma using with SH 834].
    Berndt G; Stender HS
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2399+. PubMed ID: 5529652
    [No Abstract]   [Full Text] [Related]  

  • 19. Halogen sensitization of the liver: a clinical syndrome, with two case reports.
    Keown KK; Bingham HG
    Anesth Analg; 1969; 48(5):710-4. PubMed ID: 5817946
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatotoxicity due to treatment with papaverine. Report of four cases.
    Ronnov-Jessen V; Tjernlund A
    N Engl J Med; 1969 Dec; 281(24):1333-5. PubMed ID: 5355438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.